from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0764c/cyp51

LFCtreatmentdescriptionclass of inhibitor

-0.617

Amikacinug/mL Amikacintranslation

-0.094

Cap5-10ug/mL Capreomycintranslation

-0.650

Rox10-50 ug/mL Roxithromycintranslation

-0.739

SM2-5 ug/mL Streptomycintranslation

-2.313

Tet5-10 ug/mL Tetracyclinetranslation

0.281

Rif0.2-5ug/mL Rifampicintranscription

-0.418

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.432

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.791

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.400

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.214

Clofazimine10-13 ug/mL Clofaziminerespiration

0.188

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.294

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.017

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.308

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.152

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.204

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.004

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.738

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.296

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.248

KCN5-20 ug/mL Potassium cyaniderespiration

-0.179

NaN30.2-2 mM Sodium aziderespiration

0.602

Nigericin50 uM Nigericinrespiration

1.132

TRC10-150 ug/mL Triclosanrespiration

0.249

TRZ10-25 ug/mL Thioridazinerespiration

-1.172

Valinomycin0.5-10 uM Valinomycinrespiration

-2.074

ZnSO42 mM ZnSO4respiration

0.778

menadione6-10 ug/mL Menadionerespiration

0.621

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.031

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.165

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.411

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.403

NRP_1Non-replicating persistence stage 1dosRassociated

-0.313

Amp0.2mg/mL AmpicillincellWall

-0.677

Cephalexin20-100 ug/mL CephalexincellWall

-0.143

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.024

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.600

EMB10-20 ug/mL EthambutolcellWall

-0.858

Eta12-40 ug/mL EthionamidecellWall

0.313

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.641

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.308

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.402

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.207

BZA0.12 mg/mL BenzamidearomaticAmides

-0.338

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.309

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.115

H2O24 mM hydrogen peroxideDNAdamaging

0.038

Levo10 ug/mL LevofloxacinDNAdamaging

-0.115

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.651

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.351

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.158

UVUV-irradiationDNAdamaging

0.150

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.252

Antimycin12.5-50 ug/mL Antimycin A?

0.093

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.300

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.158

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.407

PA8240.2-2 ug/mL PA-824?

-0.109

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.116

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.023

Verapamil50 uM Verapamil?

0.220

mercaptoethanol2 mM 2-Mercaptoethanol?

0.078

methoxatin10-20 ug/mL Methoxatin?